ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
ABBOTT LABORATORIES
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Jul 28, 2026
$104.06−0.83 (-0.79%)
Close on Oct 19, 2026
- Market cap
- $181.80B
- P/E (TTM)
- 29.0
- Dividend yield
- 2.31%
Dividends
Dividend declared per share by fiscal year, adjusted for stock splits
Per share, FY2025
$2.40
+7.1% on the prior year
Consecutive increases
3 years
Every year since FY2022
Dividend yield
2.31%
Latest annual dividend ÷ share price
Payout ratio, FY2025
63.1%
Dividends paid ÷ net income
Dividend history
By fiscal year
| Fiscal year | Per share | Change | Cash paid | Payout ratio |
|---|---|---|---|---|
| FY2025 | $2.40 | +7.1% | $4.12B | 63.1% |
| FY2024 | $2.24 | +7.7% | $3.84B | 28.6% |
| FY2023 | $2.08 | +8.3% | $3.56B | 62.1% |
| FY2022 | $1.92 | – | $3.31B | 47.7% |
| FY2021 | – | – | $3.20B | 45.3% |
| FY2020 | – | – | $2.56B | 57.0% |
| FY2019 | – | – | $2.27B | 61.6% |
| FY2018 | – | – | $1.97B | 83.4% |
| FY2017 | – | – | $1.85B | 387.6% |
| FY2016 | – | – | $1.54B | 109.9% |
| FY2015 | – | – | $1.44B | 32.6% |
| FY2014 | – | – | $1.34B | 58.8% |
| FY2013 | – | – | $882.00M | 34.2% |
| FY2012 | – | – | $3.18B | 53.4% |
| FY2011 | $1.92 | +9.1% | $2.94B | 62.1% |
Ex-dividend and payment dates for each distribution will appear once a dividend calendar source is connected.